Search
Burning Rock Biotech Ltd
BNRAdd to Watchlist
9.820USD
+0.860+9.60%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
88.66MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+9.60%
5 Days
+18.74%
1 Month
+7.21%
6 Months
-50.10%
Year to Date
-51.27%
1 Year
+188.82%
Key Figures
9.310Open
10.200High
29.43KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
0.33%Turnover Ratio
8.960Prev. Close
9.230Low
138.40KTurnover
LossP/E Static
1.16P/B
0.00%Div Yield TTM
-6.49%ROA
41.72052wk High
3.28Volume Ratio
-346.63MNet Profit
9.03MShares
-0.7445EPS TTM
1.38Beta
-9.92%ROE
2.80052wk Low
10.83%Amplitude
72.27%Gross Margin
88.66MMarket Cap
-0.26Reward/Risk
8.29%Risk Rate
TradingKey Stock Score of Burning Rock Biotech Ltd
Currency: USD Updated: 2026-07-02Key Insights
Burning Rock Biotech Ltd's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 61 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Burning Rock Biotech Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Burning Rock Biotech Ltd Highlights
StrengthsRisks
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Growing
The company is in a growing phase, with the latest annual income totaling USD 78.24M.
Undervalued
The company’s latest PE is -13.19, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 4.03M shares, decreasing 6.43% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Burning Rock Biotech Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Burning Rock Biotech Ltd Info
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Ticker SymbolBNR
CompanyBurning Rock Biotech Ltd
CEOHan (Yusheng)
Websitehttps://www.brbiotech.com/
Related Instruments
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+2.59%
-3.06%
+3.40%
+3.76%
+1.10%
+0.28%
-2.09%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Burning Rock Biotech Ltd (BNR)?
The current price of Burning Rock Biotech Ltd (BNR) is 9.82.
What is the symbol of Burning Rock Biotech Ltd?
The ticker symbol of Burning Rock Biotech Ltd is BNR.
What is the 52-week high of Burning Rock Biotech Ltd?
The 52-week high of Burning Rock Biotech Ltd is 41.72.
What is the 52-week low of Burning Rock Biotech Ltd?
The 52-week low of Burning Rock Biotech Ltd is 2.80.
What is the market capitalization of Burning Rock Biotech Ltd?
The market capitalization of Burning Rock Biotech Ltd is 88.66M.
What is the Earnings Per Share (EPS TTM) of Burning Rock Biotech Ltd (BNR)?
The Earnings Per Share (EPS TTM) of Burning Rock Biotech Ltd (BNR) is -0.74.